CMS Announces Decision to Cover Genomic Testing for patients With Cancer

In a national coverage determination issued March 16, CMS announced that it will cover diagnostic laboratory tests using next-generation sequencing for patients with advanced cancer.

Read full article (External website)

1 reply

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply